Enfermedad cardiovascular en las mujeres

1. Geraghty L, Figtree GA, Schutte AE, Patel S, Woodward M, Arnott C. Cardiovascular disease in women: from pathophysiology to novel and emerging risk factors. Heart Lung Circ 2021;30:9-17. https://doi.org/10.1016/ j.hlc.2020.05.108

2. Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 2021;397:2385-438. https://doi.org/ 10.1016/S0140-6736(21)00684-X

3. Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation 2019;139:1047-56. https://doi.org/10.1161/CIRCULATIONAHA.118.037137

4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. https://doi.org/10.1016/S0140-6736(04)17018-9

5. Australian Institute of Health and Welfare. Cardiovascular disease in women—a snapshot of national statistics. Canberra: AIHW; 2019.

6. Peters SA, Huxley RR, Woodward M. Comparison of the sex-specific associations between systolic blood pressure and the risk of cardiovascular disease: a systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals. Stroke 2013;44:2394-401. https://doi.org/10.1161/ STROKEAHA.113.001624

7. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005;294:466-72. https://doi.org/ 10.1001/jama.294.4.466

8. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 2018;137:e67-e492. https://doi.org/ 10.1161/CIR.0000000000000558

9. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162:1867-72. https://doi.org/10.1001/ archinte.162.16.1867

10. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011;378:1297-305. https://doi.org/10.1016/ S0140-6736(11)60781-2

11. Young L, Cho L. Unique cardiovascular risk factors in women. Heart 2019;105:1656-60. https://doi.org/10.1136/ heartjnl-2018-314268

12. Bellettiere J, LaMonte MJ, Evenson KR, Rillamas‑Sun E, Kerr J, Lee IM, et al. Sedentary behavior and cardiovascular disease in older women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study. Circulation 2019;139:1036-46. https://doi.org/10.1161/ CIRCULATIONAHA.118.035312

13. Jefferis BJ, Sartini C, Lee IM, Choi M, Amuzu A, Gutierrez C, et al. Adherence to physical activity guidelines in older adults, using objectively measured physical activity in a population-based study. BMC Public Health 2014;14:382. https://doi.org/10.1186/1471-2458-14-382

14. Prata J, Ramos S, Martins AQ, Rocha-Goncalves F, Coelho R. Women with coronary artery disease: do psychosocial factors contribute to a higher cardiovascular risk? Cardiol Rev 2014;22:25-9. https://doi.org/10.1097/ CRD.0b013e31829e852b

15. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five‑year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105:1049-53. https://doi.org/10.1161/hc0902.104707

16. Denollet J, Martens EJ, Smith OR, Burg MM. Efficient assessment of depressive symptoms and their prognostic value in myocardial infarction patients. J Affect Disord 2010;120:105-11. https://doi.org/10.1016/j.jad.2009.04.013

17. Garcia-Moreno C, Jansen HA, Ellsberg M, Heise L, Watts CH, Health WHOM-cSoWs, et al. Prevalence of intimate partner violence: findings from the WHO multi-country study on women’s health and domestic violence. Lancet 2006;368:1260-9. https://doi.org/10.1016/S0140-6736(06)69523-8

18. Breiding MJ, Black MC, Ryan GW. Chronic disease and health risk behaviors associated with intimate partner violence-18 U.S. states/territories, 2005. Ann Epidemiol 2008;18:538-44. https://doi.org/10.1016/j.annepidem.2008.02.005

19. Curtis KM, Mohllajee AP, Martins SL, Peterson HB. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception 2006;73:179-88. https://doi.org/10.1016/j.contraception.2005.08.005

20. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988;319:1313-7. https://doi.org/10.1056/ NEJM198811173192004

21. Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Pre‑eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 2014;63:1815-22. https://doi.org/ 10.1016/j.jacc.2014.02.529

22. Leon LJ, McCarthy FP, Direk K, Gonzalez-Izquierdo A, Prieto‑Merino D, Casas JP, et al. Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records: A CALIBER Study. Circulation 2019;140:1050-60. https://doi.org/10.1161/ CIRCULATIONAHA.118.038080

23. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011;123:2856-69. https://doi.org/10.1161/ CIRCULATIONAHA.109.853127

24. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-9. https://doi.org/10.1016/S0140-6736(09)60731-5

25. Janssen I, Powell LH, Crawford S, Lasley B, Sutton‑Tyrrell K. Menopause and the metabolic syndrome: the study of women’s health across the nation. Arch Intern Med 2008;168:1568-75. https://doi.org/10.1001/archinte.168.14.1568

26. Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, et al. Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol 2018;71:2555-66. https://doi.org/10.1016/ j.jacc.2018.01.083

27. Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, et al. Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA 2019;322:2411-21. https://doi.org/10.1001/jama.2019.19191

28. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310:1353-68. https://doi.org/10.1001/jama.2013.278040

29. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77. https://doi.org/ 10.1001/jama.297.13.1465

30. Peters SA, Woodward M. Women’s reproductive factors and incident cardiovascular disease in the UK Biobank. Heart 2018;104:1069-75. https://doi.org/10.1136/ heartjnl-2017-312289

31. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007;49:90-5. https://doi.org/10.1161/01.HYP.0000251522.18094.d4

32. Zhao L, Zhu Z, Lou H, Zhu G, Huang W, Zhang S, et al. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget 2016;7:33715-21. https://doi.org/10.18632/oncotarget.9553

33. Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril 2014;102:1444-51.e3. https://doi.org/10.1016/j.fertnstert.2014.08.001

34. Venkatesulu BP, Mahadevan LS, Aliru ML, Yang X, Bodd MH, Singh PK, et al. Radiation-induced endothelial vascular injury: a review of possible mechanisms. JACC Basic Transl Sci 2018;3:563-72. https://doi.org/10.1016/j.jacbts.2018.01.014

35. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987-98. https://doi.org/10.1056/NEJMoa1209825

36. Khalid Y, Fradley M, Dasu N, Dasu K, Shah A, Levine A. Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin’s lymphoma: a systematic review. Cardiooncology 2020;6:12. https://doi.org/10.1186/ s40959-020-00067-7

37. Liu E, Guan X, Wei R, Jiang Z, Liu Z, Wang G, et al. Association between radiotherapy and death from cardiovascular disease among patients with cancer: a large population-based cohort study. J Am Heart Assoc 2022;11:e023802. https://doi.org/10.1161/JAHA.121.023802